Author： Boggi Ugo Vistoli Fabio Signori Stefano Del Chiaro Marco Amorese Gabriella Barsotti Massimiliano Rizzo Gaetano Marchetti Piero Danesi Romano Del Tacca Mario Mosca Franco
Publisher： Informa Healthcare
ISSN： 1474-0338
Source： Expert Opinion on Drug Safety, Vol.4, Iss.3, 2005-05, pp. : 473-490
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
The use of basiliximab in solid organ transplantation
By Henry Mitchell L Rajab Amer
Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 11, 2002-11 ,pp. :
Gene Therapy in Kidney Transplantation: Evidence of Efficacy and Future Directions
Current Gene Therapy, Vol. 17, Iss. 6, 2018-03 ,pp. :
Basiliximab: economic advantage for renal transplantation in Japan
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 405, 2003-01 ,pp. :
A Benefit-Risk Assessment of Basiliximab in Renal Transplantation
By Boggi Ugo
Drug Safety, Vol. 27, Iss. 2, 2004-01 ,pp. :